Publications
5543 Results
- Journal / Conference
- Leukemia Jul;38(7):1488-1493
- Year
- 2024
- Research Committee(s)
- Leukemia
- PMID
- PMID38830960
- Study Number(s)
- S1203
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203
- Journal / Conference
- JAMA Network Open Aug 1;7(8):e2425288
- Year
- 2024
- Research Committee(s)
- Genitourinary
- PMID
- PMID39106067
- PMC
- PMC11304111
- Study Number(s)
- S0931
Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial
- Journal / Conference
- Annals of Surgical Oncology Jul 15. doi: 10.1245/s10434-024-15670-6. Online ahead of print
- Year
- 2024
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID39008208
- Study Number(s)
- CTSU/A021501
Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501)
- Journal / Conference
- Journal for ImmunoTherapy of Cancer Jan 11;12(1):e007939
- Year
- 2024
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID38212126
- PMC
- PMC10806545
- Study Number(s)
- CTSU/C80405
CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value
- Journal / Conference
- Journal of Clinical Oncology Jun 1;42(16):1890-1902
- Year
- 2024
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID38457761
- PMC
- PMC11240881
- Study Number(s)
- CTSU/C80405
HER2 gene expression levels are predictive and prognostic in patients with metastatic colorectal cancer enrolled in CALGB/SWOG 80405
- Journal / Conference
- Journal of Clinical Oncology Aug 20;42(24):2853-2859
- Year
- 2024
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID38889377
- Study Number(s)
- CTSU/C80702
Improved survival with adjuvant COX-2 inhibition in PIK3CA-activated stage III colon cancer
- Journal / Conference
- JAMA Network Open Jan 2;7(1):e2350844
- Year
- 2024
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID38194233
- PMC
- PMC10777253
Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer
- Journal / Conference
- Communications Biology Apr 2;7(1):400
- Year
- 2024
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID38565955
- PMC
- PMC11255321
- Study Number(s)
- CTSU/C80405
q-Diffusion leverages the full dimensionality of gene coexpression in single-cell transcriptomics
- Journal / Conference
- Breast Cancer Research and Treatment Sep;207(2):275-282
- Year
- 2024
- Research Committee(s)
- Breast
- PMID
- PMID38967884
- PMC
- PMC11297090
- Study Number(s)
- CTSU/E1105
A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu over-expressing metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
- Journal / Conference
- JCO Precision Oncology Jul:8:e2300725
- Year
- 2024
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID38986051
- Study Number(s)
- CTSU/EAY131